Pure Global Cannabis Inc. Completes Reverse Takeover Transaction with PureSinse Inc.

Published: July 10, 2018

Pure Global Cannabis Inc. Completes Reverse Takeover Transaction with PureSinse Inc.

Pure Global Cannabis Inc. completed its previously announced amalgamation and reverse takeover transaction with PureSinse Inc.

PureSinse is a life science cannabis company based in Toronto. It is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing premium-quality cannabis products for medical, wellness and future legal adult recreational use from its state-of-the-art, strategically-located flagship facility in Brampton, Ontario. PureSinse’s initial site is an 18,000-square-foot facility, with a fully-funded option to expand to 41,000 square feet, that will soon be a hub for processing, production, research and development, and distribution, located in the heart of the Greater Toronto Area. Utilizing modern commercial horticulture and hydroponic techniques, the site is expected to produce over 8,000 kilograms of premium-quality dried cannabis per year and will be looking to significantly expand output in the near term.

Trading in the common shares of RS was previously halted on March 12, 2018 at the request of RS upon announcement of the Transaction. Trading in the common shares of Pure Global will commence on the TSX Venture Exchange at market open on Wednesday July 11, 2018 under the symbol “PURE”.